Stay updated with breaking news from Code Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, today announced that Angèle Maki, Ph.D., Senior Vice President, Business Development of ReCode Therapeutics, will present a company overview a...
Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) and TransCode Therapeutics (NASDAQ:RNAZ – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation. Insider and Institutional Ownership 15.9% of TransCode Therapeutics shares […]
Gainers Clearmind Medicine Inc. (NASDAQ:CMND) gained 61.5% to $0.88 in pre-market trading after dropping around 3% on Tuesday. Clearmind engaged...
– Renowned physician-scientist brings deep expertise in clinical development and inhaled drug delivery to ReCode as lead programs for primary ciliary dyskinesia and cystic fibrosis enter clinical trials –MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using superi...
BOSTON, April 06, 2023 -- TransCode Therapeutics, Inc. , the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it will... | April 6, 2023